{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:46:32Z","timestamp":1788259592168,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00415-021-10457-1","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T05:25:16Z","timestamp":1614403516000},"page":"3000-3010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent seizures of autoimmune origin: emerging phenotypes"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-3323","authenticated-orcid":false,"given":"Mathilde","family":"Goudot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Frismand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Hopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Tyvaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"issue":"6","key":"10457_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4065\/71.6.576","volume":"71","author":"WA Hauser","year":"1996","unstructured":"Hauser WA, Annegers JF, Rocca WA (1996) Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 71(6):576\u2013586","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10457_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4065\/71.6.570","volume":"71","author":"JF Annegers","year":"1996","unstructured":"Annegers JF, Rocca WA, Hauser WA (1996) Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc 71(6):570\u2013575","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10457_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM200002033420503","volume":"342","author":"P Kwan","year":"2000","unstructured":"Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342(5):314\u2013319","journal-title":"N Engl J Med"},{"issue":"12","key":"10457_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091\u20131098","journal-title":"Lancet Neurol"},{"issue":"Pt 4","key":"10457_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/aww012","volume":"139","author":"V Navarro","year":"2016","unstructured":"Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P et al (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139(Pt 4):1079\u20131093","journal-title":"Brain"},{"issue":"6","key":"10457_CR6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/epi.12127","volume":"54","author":"T Brenner","year":"2013","unstructured":"Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ et al (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54(6):1028\u20131035","journal-title":"Epilepsia"},{"issue":"2","key":"10457_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WCO.0000000000000304","volume":"29","author":"S Wright","year":"2016","unstructured":"Wright S, Vincent A (2016) Progress in autoimmune epileptic encephalitis. Curr Opin Neurol 29(2):151\u2013157","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10457_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","volume":"74","author":"D Dubey","year":"2017","unstructured":"Dubey D, Alqallaf A, Hays R, Freeman M, Chen K, Ding K et al (2017) Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 74(4):397\u2013402","journal-title":"JAMA Neurol"},{"issue":"4","key":"10457_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11845-018-1777-2","volume":"187","author":"M Tecellioglu","year":"2018","unstructured":"Tecellioglu M, Kamisli O, Kamisli S, Yucel FE, Ozcan C (2018) Neurological autoantibodies in drug-resistant epilepsy of unknown cause. Ir J Med Sci 187(4):1057\u20131063","journal-title":"Ir J Med Sci"},{"issue":"8","key":"10457_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/jnnp.2008.165860","volume":"80","author":"BM Soeder","year":"2009","unstructured":"Soeder BM, Gleissner U, Urbach H, Clusmann H, Elger CE, Vincent A et al (2009) Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy. J Neurol Neurosurg Psychiatry 80(8):894\u2013899","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10457_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.eplepsyres.2017.06.008","volume":"135","author":"G Gozubatik-Celik","year":"2017","unstructured":"Gozubatik-Celik G, Ozkara C, Ulusoy C, Gunduz A, Delil S, Yeni N et al (2017) Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Res 135:131\u2013136","journal-title":"Epilepsy Res"},{"issue":"18","key":"10457_CR12","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Kang CC, Probasco JC, Jongeling AC et al (2015) New-onset refractory status epilepticus. Neurology 85(18):1604\u20131613","journal-title":"Neurology"},{"key":"10457_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yebeh.2018.05.043","volume":"91","author":"M S\u00fc\u00dfe","year":"2019","unstructured":"S\u00fc\u00dfe M, Hamann L, Fl\u00f6el A, von Podewils F (2019) Nonlesional late-onset epilepsy: semiology, EEG, cerebrospinal fluid, and seizure outcome characteristics. Epilepsy Behav 91:75\u201380","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10457_CR14","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/epi.13834","volume":"58","author":"F von Podewils","year":"2017","unstructured":"von Podewils F, Suesse M, Geithner J, Gaida B, Wang Z, Lange J et al (2017) Prevalence and outcome of late-onset seizures due to autoimmune etiology: a prospective observational population-based cohort study. Epilepsia 58(9):1542\u20131550","journal-title":"Epilepsia"},{"issue":"7","key":"10457_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/jnnp-2016-313146","volume":"87","author":"EN Vanli-Yavuz","year":"2016","unstructured":"Vanli-Yavuz EN, Erdag E, Tuzun E, Ekizoglu E, Baysal-Kirac L, Ulusoy C et al (2016) Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 87(7):684\u2013692","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10457_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC, Godot A, Irani S, Linnoila J et al (2020) Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune associated epilepsy: conceptual definitions. Epilepsia 61:1341\u20131351","journal-title":"Epilepsia"},{"issue":"9","key":"10457_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","volume":"73","author":"B Joubert","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F et al (2016) Characterization of a subtype of autoimmune encephalitis with anti\u2013contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol 73(9):1115\u20131124","journal-title":"JAMA Neurol"},{"issue":"2","key":"10457_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141(2):348\u2013356","journal-title":"Brain"},{"issue":"4","key":"10457_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5698\/1535-7597.17.4.225","volume":"17","author":"A Bermeo-Ovalle","year":"2017","unstructured":"Bermeo-Ovalle A (2017) Scratching the surface in autoimmune epilepsy: it is the time to dig deeper, but how? Epilepsy Curr 17(4):225\u2013226","journal-title":"Epilepsy Curr"},{"issue":"4","key":"10457_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391\u2013404","journal-title":"Lancet Neurol"},{"issue":"8","key":"10457_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/ene.13661","volume":"25","author":"F Graus","year":"2018","unstructured":"Graus F, Escudero D, Oleaga L, Bruna J, Villarejo-Galende A, Ballabriga J et al (2018) Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol 25(8):1011\u20131016","journal-title":"Eur J Neurol"},{"issue":"12","key":"10457_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","volume":"71","author":"F Graus","year":"2008","unstructured":"Graus F, Saiz A, Lai M, Bruna J, Lopez F, Sabater L et al (2008) Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71(12):930\u2013936","journal-title":"Neurology"},{"issue":"7","key":"10457_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/epi.13797","volume":"58","author":"D Dubey","year":"2017","unstructured":"Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA et al (2017) Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia 58(7):1181\u20131189","journal-title":"Epilepsia"},{"issue":"10","key":"10457_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.braindev.2018.06.002","volume":"40","author":"P Tekturk","year":"2018","unstructured":"Tekturk P, Baykan B, Erdag E, Peach S, Sezgin M, Yapici Z et al (2018) Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause. Brain Dev 40(10):909\u2013917","journal-title":"Brain Dev"},{"issue":"1","key":"10457_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/WNN.0b013e318190d195","volume":"22","author":"A Modoni","year":"2009","unstructured":"Modoni A, Masciullo M, Spinelli P, Marra C, Tartaglione T, Andreetta F et al (2009) Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies. Cogn Behav Neurol 22(1):63\u201366","journal-title":"Cogn Behav Neurol"},{"issue":"2","key":"10457_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/WNN.0b013e3182248193","volume":"24","author":"S Najjar","year":"2011","unstructured":"Najjar S, Pearlman D, Zagzag D et al (2011) Spontaneously resolving seronegative autoimmune limbic encephalitis. Cogn Behav Neurol 24(2):99\u2013105","journal-title":"Cogn Behav Neurol"},{"issue":"1","key":"10457_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/WNN.0b013e31828b6531","volume":"26","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman D, Devinsky O, Devinsky O (2013) Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review. Cogn Behav Neurol 26(1):36\u201349","journal-title":"Cogn Behav Neurol"},{"issue":"3","key":"10457_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/WNN.0000000000000134","volume":"30","author":"J Toro","year":"2017","unstructured":"Toro J, Cuellar-Giraldo D, Duque A, Minota K, Patino J, Garcia M (2017) Seronegative paraneoplastic limbic encephalitis associated with thymoma. Cogn Behav Neurol 30(3):125\u2013128","journal-title":"Cogn Behav Neurol"},{"issue":"Pt 7","key":"10457_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","volume":"123","author":"SH Gultekin","year":"2000","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123(Pt 7):1481\u20131494","journal-title":"Brain"},{"issue":"6","key":"10457_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/practneurol-2011-000084","volume":"11","author":"SAB Ahmad","year":"2011","unstructured":"Ahmad SAB, Archer HA, Rice CM, Gerhand S, Bradley M, Wilkins A (2011) Seronegative limbic encephalitis: case report, literature review and proposed treatment algorithm. Pract Neurol 11(6):355\u2013361","journal-title":"Pract Neurol"},{"issue":"9","key":"10457_CR31","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1097\/RLU.0b013e31824852c7","volume":"37","author":"RE Fisher","year":"2012","unstructured":"Fisher RE, Patel NR, Lai EC, Schulz PE (2012) Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 37(9):e213-218.32","journal-title":"Clin Nucl Med"},{"issue":"1 Epilepsy","key":"10457_CR32","first-page":"227","volume":"22","author":"N Gaspard","year":"2016","unstructured":"Gaspard N (2016) Autoimmune epilepsy. Continuum 22(1 Epilepsy):227\u2013245","journal-title":"Continuum"},{"issue":"1","key":"10457_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J et al (2010) Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67\u201376","journal-title":"Lancet Neurol"},{"key":"10457_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","volume":"80","author":"A Daif","year":"2018","unstructured":"Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT et al (2018) Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav 80:331\u2013336","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10457_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/cjn.2016.13","volume":"43","author":"M-M Gagnon","year":"2016","unstructured":"Gagnon M-M, Savard M (2016) Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci 43(4):486\u2013493","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"10457_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","volume":"19","author":"M Falip","year":"2012","unstructured":"Falip M, Carre\u00f1o M, Mir\u00f3 J, Saiz A, Villanueva V, Quilez A et al (2012) Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol 19(6):827\u2013833","journal-title":"Eur J Neurol"},{"issue":"281","key":"10457_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","volume":"15","author":"J-S Sunwoo","year":"2015","unstructured":"Sunwoo J-S, Lee S-T, Byun J-I, Moon J, Shin J-W, Jeong D-E et al (2015) Clinical manifestations of patients with CASPR2 antibodies. J Neuroimmunol 15(281):17\u201322","journal-title":"J Neuroimmunol"},{"key":"10457_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2017.08.011","volume":"77","author":"C Chen","year":"2017","unstructured":"Chen C, Wang X, Zhang C, Tao C, Shi W-X, Guan H-Z et al (2017) Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis. Epilepsy Behav 77:90\u201395","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10457_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","volume":"1","author":"M-S Ong","year":"2014","unstructured":"Ong M-S, Kohane IS, Cai T, Gorman MP, Mandl KD (2014) Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol 1(5):569\u2013574","journal-title":"JAMA Neurol"},{"issue":"3","key":"10457_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabet.2012.02.005","volume":"38","author":"M Lopez-Sublet","year":"2012","unstructured":"Lopez-Sublet M, Bihan H, Reach G, Dupont S, Didelot A, Mourad J-j et al (2012) Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy. Diabetes Metab 38(3):273\u2013275","journal-title":"Diabetes Metab"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10457-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:38:59Z","timestamp":1626737939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10457-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10457"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10457-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the ethical standards recognized internationally.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}